Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study-Reference-Cited by-同舟云学术

Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study

Published:2021 Issue: Volume: Page:
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Naito Ryo¹,Daida Hiroyuki¹,Masuda Daisaku²,Harada-Shiba Mariko³,Arai Hidenori⁴,Bujo Hideaki⁵,Ishibashi Shun⁶,Koga Nobuhiko⁷,Oikawa Shinichi⁸,Yamashita Shizuya²,

Affiliation:

1. Department of Cardiovascular Biology and Medicine, Juntendo University

2. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine

3. Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute

4. The National Center for Geriatrics and Gerontology

5. Department of Clinical Laboratory and Experimental Research Medicine, Toho University, Sakura Medical Center

6. Division of Endocrinology and Metabolism, Department of Medicine, Jichi Medical University

7. Shin Koga Hospital

8. Director of Diabetes and Lifestyle-related Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association (JATA)

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_63019/_pdf

Reference50 articles.

1. 1) Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Luis Masana, Reiner Z, Taskinen M-R, Tokgözoglu L, Tybjærg-Hansen A, European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J, 2010; 31: 2844-2853

2. 2) Emerging Risk Factors Collaboration; Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA, 2009; 302: 412-423

3. 3) Kamstrup PR, Benn M, Tybjærg-Hansen A, Nordestgaard BG. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation, 2008; 117: 176-184

4. 4) McGowan MP, Dehkordi SHH, Moriarty PM, Duell PB. Diagnosis and treatment of heterozygous familial hypercholesterolemia. J Am Heart Assoc, 2019; 8: e013225

5. 5) Bujo H, Takahashi K, Saito Y, Maruyama T, Yamashita S, Matsuzawa Y, Ishibashi S, Shionoiri F, Yamada N, Kita T, Research Committee on Primary Hyperlipidemia of the Ministry of Health, Labour, and Welfare of Japan. Clinical features of familial hypercholesterolemia in Japan in a database from 1996−1998 by the Research Committee of the Ministry of Health, Labour and Welfare of Japan. J Atheroscler Thromb, 2004; 11: 146-151

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Omega-3 Fatty Acid Supplementation on the Postprandial Metabolism of Apolipoprotein(a) in Familial Hypercholesterolemia;Journal of Atherosclerosis and Thrombosis;2023-03-01

2. Synergistic effect of lipoprotein (a) and C-reactive protein on prognosis of familial hypercholesterolemia;American Journal of Preventive Cardiology;2022-12

3. Impact of High-Density Lipoprotein Function, Rather Than High-Density Lipoprotein Cholesterol Level, on Cardiovascular Disease Among Patients With Familial Hypercholesterolemia;Circulation Journal;2022-11-26

4. Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular Prevention;Metabolites;2022-11-04

5. How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?;Journal of Atherosclerosis and Thrombosis;2022-06-01